PAWR and prostate cancer: Our in vitro and in vivo studies suggest the potential of plant-derived SAC-Par-4-GFP as a therapeutic agent against prostate cancer cells; however, further extensive studies are essential to evaluate the efficacy of this protein in a more clinically relevant model.